Skip to main content
Figure 2 | Lipids in Health and Disease

Figure 2

From: Effect of the dietary supplement Meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study

Figure 2

Plasma epinephrine (A) and norepinephrine (B) data for men and women consuming Meltdown® and placebo in a randomized cross-over design. Data are mean ± SEM. * Greater epinephrine (367 ± 58 pg·mL-1·6 hr-1 vs. 183 ± 27 pg·mL-1·6 hr-1; p = 0.01) and norepinephrine (2345 ± 205 pg·mL-1·6 hr-1 vs. 1659 ± 184 pg·mL-1·6 hr-1; p = 0.02) AUC for Meltdown® compared to placebo.

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X